Company intelligence / Profile preview

Bel Mar Laboratories

Inwood, New York, United States

Ownership: Private
Development stage: Other

Overview

Bel-Mar Laboratories was a pharmaceutical company focused on the development and manufacture of sterile injectable medications. Headquartered in Inwood, New York, the firm produced a variety of specialty generics, including hormones, vitamins, and local anesthetics. The company was acquired by Akorn, Inc. in 1995 to bolster Akorn's presence in the injectable drug market. Bel-Mar operated as a subsidiary and manufacturing site until its parent company, Akorn, filed for Chapter 7 bankruptcy and ceased all operations in February 2023. Consequently, Bel-Mar Laboratories is currently inactive.

Therapeutic areas: HematologyEndocrinologyWomen's Health
Modalities: Small moleculeHormoneBiologic
Industry: Biotech

Beyond the preview

Go deeper on Bel Mar Laboratories.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Bel Mar Laboratories.

Explore the full profile